North Star Investment Management’s Coya Therapeutics COYA Stock Holding History

North Star Investment Management’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99K	Hold	340	–	–	﹤0.01%	1425
2026 Q1	$1.34K	Buy	+340	New	+$1.59K	﹤0.01%	1453

Other funds holding COYA

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

North Star Investment Management's COYA Position: Q2 2026 in Review

North Star Investment Management held its Coya Therapeutics (COYA) position steady in Q2 2026 at 340 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

North Star Investment Management first reported a position in COYA in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

North Star Investment Management held 340 shares of Coya Therapeutics worth $1.99K as of Q2 2026.
North Star Investment Management left its Coya Therapeutics share count unchanged in Q2 2026.
Coya Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1425 holding.
North Star Investment Management first reported a position in Coya Therapeutics in Q1 2026 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.